Lindbrook Capital, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 90 filers reported holding UROGEN PHARMA LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2021$9,000
+200.0%
513
+198.3%
0.00%
+100.0%
Q2 2021$3,000
-40.0%
172
-38.1%
0.00%0.0%
Q1 2021$5,000
-16.7%
278
-21.9%
0.00%0.0%
Q4 2020$6,000
-14.3%
356
-3.5%
0.00%
-50.0%
Q3 2020$7,000
-46.2%
369
-24.7%
0.00%
-50.0%
Q2 2020$13,000
+225.0%
490
+146.2%
0.00%
+100.0%
Q1 2020$4,000
-55.6%
199
-26.3%
0.00%
-33.3%
Q4 2019$9,0002700.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders